Back
Speaker illustration

Doctor Anastasios Apostolos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

Member of:

European Society of Cardiology

Anastasios Apostolos, MD, MSc was born in 1996 in Athens, Greece. He studied Medicine in the University of Patras and he graduated in August, 2020. Nowadays, he serves as PhD student in the First Department of Cardiology, University of Athens, Hippokration General Hospital. His PhD subject is "Investigation of Nickel Sensitization After Percutaneous Implantation of Patent Foramen Ovale Occluder (INSPIRE)". His main research interests are interventional cardiology, coronary artery disease, structural heart diseases and heart failure. He has more than 50Pubmed-indexed publications in highly cited journals, such as BMJ, EHJ, JACC, Circulation, JACC: Cardiovascular Interventions, etc.

Presentations Articles

Shortened versus standard duration of dual antiplatelet treatment after percutaneous coronary intervention in patients with and without chronic kidney disease: a systematic review and meta-analysis

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Cardiovascular pharmacotherapy: new insights

Access
Like
Thumbnail

Transcatheter patent foramen ovale closure in patients with and without documented nickel hypersensitivity

Event: ESC Congress 2024

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Advances in left atrial appendage and patent foramen ovale closure

Access
Like
Thumbnail

Sex-related outcomes in patients receiving shortened or longer dual antiplatelet treatment after percutaneous coronary intervention: a systematic review and meta-analysis.

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Novel and old treatments, evidence in large populations

Access
Like
Thumbnail

Mortality rates in patients undergoing urgent versus elective transcatheter aortic valve replacement: a systematic review and meta-analysis.

Event: ESC Congress 2024

Topic: Intervention

Session: New frontiers in treatment of valvular heart diseases

Access
Like
Thumbnail

Antithrombotic treatment after transcatheter patent foramen ovale closure in patients with previous cryptogenic stroke.

Event: ESC Preventive Cardiology 2024

Topic: Congenital Heart Disease

Session: Assessing and managing cardiovascular risk after interventions and surgery

Access
Like
Thumbnail

Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure.

Event: ESC Preventive Cardiology 2024

Topic: Congenital Heart Disease

Session: Assessing and managing cardiovascular risk after interventions and surgery

Access
Like
Thumbnail

Management of patent foramen ovale; findings from a nationwide survey

Event: ESC Preventive Cardiology 2024

Topic: Congenital Heart Disease

Session: Diagnosis and management of cardiovascular risk in high-risk patients

Access
Like
Thumbnail

Trends in antithrombotic treatment after cryptogenic stroke and prior transcatheter patent foramen ovale closure.

Event: ESC Preventive Cardiology 2024

Topic: Congenital Heart Disease

Session: Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

Access
Like
Thumbnail

Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Antiplatelet Drugs

Session: Short and long-term antiplatelet therapy in clinical practice

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources